TITLE

Understanding the Rx financial trail: Who pays what, when, where and why

AUTHOR(S)
MCCLURG, JACK
PUB. DATE
January 2009
SOURCE
Employee Benefit News;Jan2009, Vol. 23 Issue 1, p41
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the process price is determined for prescription medications. Common influences include market demand and competition in the marketplace and the price paid to pharmacies for dispensing the drug. The manufacturer examines other factors such as rebates or bonuses once the average wholesale price (AWP) is established. Generic medications are usually priced by a unique formula known as maximum allowable cost. The actions that can be taken by employers to influence the cost of medications are outlined.
ACCESSION #
36351675

 

Related Articles

  • Savings from Generic Prescriptions. Horvitz, Richard A.; Morgan, John P.; Fleckenstein, Lawrence // Annals of Internal Medicine;May75, Vol. 82 Issue 5, p601 

    Presents a study which surveyed cost savings of generic drugs in retail pharmacies of Rochester, New York. Methods; List of brand and generic drug prices; Results and discussion.

  • How to Save Big on Rx.  // Consumer Reports;Dec2014, Vol. 79 Issue 12, p20 

    The article discusses the purchasing of discounted generic drugs at large retail stores, focusing on suggestions to consumers on how to save money. Topics include the difference in the price of drugs purchased through insurance versus those available in bulk at stores and consideration of...

  • Medicare Drug Discounts Offer No Savings for Savvy Consumers According to PharmacyChecker.com.  // Townsend Letter for Doctors & Patients;Jul2004, Issue 252, p18 

    Reports on the review of the discounted prices recently released on the new Medicare drug card website by PharmacyChecker.Com in the U.S. Results revealing U.S. consumer savings relative to purchasing at wholesale pharmacies; Comparison of the drug prices between the lowest Medicare card prices...

  • 'Mom and Pop' no more. Silva, Chris // Employee Benefit News;Jan2007, Vol. 21 Issue 1, p30 

    The article focuses on the use of 1 Price Prescription program by independent pharmacies in the U.S. Developed by Dan Benamoz, chief executive officer (CEO) of Pharmacy Development Services (PDS), the program promotes the sale of a large list of generic drugs. Pharmacy owner Denise Weaver has...

  • Medicare Part D to require disclosure of generic options. Samalonis, Lisa B. // Drug Topics;8/8/2005 Supplement, p20s 

    This article discusses the disclosure of generic options required by Medicare Part D in the United States. Prescription drug plans (PDP) must ensure that pharmacies inform enrollees of the price differential between a brand name drug and the lowest-priced generic version when a covered drug is...

  • GPOs: Strength in numbers. DeBenedette, Valerie // Drug Topics;Jun2012, Vol. 156 Issue 6, p20 

    The article discusses plight of those independent pharmacies which are competing with the big chains and big-box stores when a number of important branded prescription products are about to go off patent. It suggests that those independent pharmacies need to join group purchasing organization...

  • Whoever at Wal-Mart thought of $4 prescriptions. Molpus, Jim // HealthLeaders Magazine;Nov2007, Vol. 10 Issue 11, p34 

    The article focuses on the move of Wal-Mart to sell over 300 generic drugs for only $4. The drugs include the diabetes drug metformin, the anticoagulant warfarin and the antibiotic amoxicillin. The author applauds Wal-Mart's initiative but notes that the company has 3,810 pharmacies in the U.S....

  • New drugs, price hikes roil a resilient generics market. FREDERICK, JAMES // Drug Store News;2/15/99, Vol. 21 Issue 3, p63 

    Probes into the status of the generics market in the United States. Factors that drive generic substitutions; Comments from industry officials; Impact of consumers' demand.

  • Generics in India and Europe evaluated.  // PharmacoEconomics & Outcomes News;11/3/2007, Issue 540, p13 

    The article focuses on a study which compared the prices of generic drugs in Europe and India. According to researchers, there may be potential for lessening prices of generic medicines in several countries. It cites that India had the lowest average unit price for eight of the medicines...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics